ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Learning from Remission and Relapse in SLE

Active
Institution
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH, NY
Principal investigator
Betty Diamond
Funding
$2.7M
Duration
2024–2029
Open portfolio

Moonbase score

Still being scored

Abstract

Abstract – Overview This program project is an exploration of patients with Systemic Lupus Erythematosus who are in long term clinical remission on no corticosteroid or immunosuppressive medication. We will study blood immune cells at the single cell level exploring distribution of cellular subsets and transcriptional, epigenetic and proteomic profiles, as well as the repertoire of naive and memory B cells reactive with nuclear antigens. We will explore brain function in these patients to determine if there is ongoing inflammation in the central nervous system in some patients despite a lack of inflammation in the periphery. Given the now recognized interplay of the immune system and the brain, we will seek correlations between immune cell profile and brain function. As approximately 25% of patients in remission can be expected to relapse over 5 years, we will seek predictors of relapse. These studies should teach us about patient heterogeneity, novel states of immune or brain homeostasis, and predictors of sustained remission or flare.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESP01ZAI1-LP-I(S1)remissionrelapseimmunepredictorsbrain functionflarecorticosteroidpatients despite

Questions for FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.